Pdt Partners, LLC Unity Biotechnology, Inc. Transaction History

Pdt Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.3 - $3.17 $97,601 - $237,997	-75,078 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.5 $2,619 - $4,050	900 Added 1.21%	75,078 $225,000
Q2 2021 Aug 16, 2021	BUY	$4.15 - $6.3 $16,371 - $24,853	3,945 Added 5.62%	74,178 $344,000
Q1 2021 May 17, 2021	SELL	$5.51 - $9.42 $47,204 - $80,701	-8,567 Reduced 10.87%	70,233 $421,000
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $115,938 - $215,604	33,900 Added 75.5%	78,800 $413,000

Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $31,872 - $134,753	10,841 Added 31.83%	44,900 $155,000
Q2 2020 Aug 14, 2020	BUY	$5.28 - $9.67 $32,699 - $59,886	6,193 Added 22.22%	34,059 $296,000
Q1 2020 May 15, 2020	BUY	$5.0 - $7.6 $21,215 - $32,246	4,243 Added 17.96%	27,866 $162,000
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $141,501 - $197,960	23,623 New	23,623 $170,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $18.4M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.